Cargando…

New Strategy for COVID-19: An Evolutionary Role for RGD Motif in SARS-CoV-2 and Potential Inhibitors for Virus Infection

Detalles Bibliográficos
Autores principales:	Yan, Shijia, Sun, Haixia, Bu, Xianzhang, Wan, Guohui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303337/ https://www.ncbi.nlm.nih.gov/pubmed/32595513 http://dx.doi.org/10.3389/fphar.2020.00912

Ejemplares similares

Fusion assays for screening of fusion inhibitors targeting SARS-CoV-2 entry and syncytia formation
por: Chan, Shiu-Wan
Publicado: (2022)

Biological and Clinical Consequences of Integrin Binding via a Rogue RGD Motif in the SARS CoV-2 Spike Protein
por: Makowski, Lee, et al.
Publicado: (2021)

Mitochondria Targeted Viral Replication and Survival Strategies—Prospective on SARS-CoV-2
por: Gatti, Priya, et al.
Publicado: (2020)

Recent Progress of RGD Modified Liposomes as Multistage Rocket Against Cancer
por: Sheikh, Afsana, et al.
Publicado: (2022)

Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4(+) and CD8(+) T cells promote cellular immune responses
por: Huang, Jun, et al.
Publicado: (2007)

Anti-SARS-CoV Natural Products With the Potential to Inhibit SARS-CoV-2 (COVID-19)
por: Verma, Surjeet, et al.
Publicado: (2020)

Potency, Safety, and Pharmacokinetic Profiles of Potential Inhibitors Targeting SARS-CoV-2 Main Protease
por: Mengist, Hylemariam Mihiretie, et al.
Publicado: (2021)

SARS-CoV-2 Treatment Approaches: Numerous Options, No Certainty for a Versatile Virus
por: Iacob, Simona, et al.
Publicado: (2020)

Screening of potential inhibitors targeting the main protease structure of SARS-CoV-2 via molecular docking
por: Yang, Xinbo, et al.
Publicado: (2022)

Vulnerabilities of the SARS-CoV-2 Virus to Proteotoxicity—Opportunity for Repurposed Chemotherapy of COVID-19 Infection
por: Al-Motawa, Maryam S., et al.
Publicado: (2020)

The RGD motif in fibronectin is essential for development but dispensable for fibril assembly
por: Takahashi, Seiichiro, et al.
Publicado: (2007)

Tuning RGD Motif and Hyaluronan Density to Study Integrin Binding
por: Zapp, Cornelia, et al.
Publicado: (2018)

Residue analysis of a CTL epitope of SARS-CoV spike protein by IFN-gamma production and bioinformatics prediction
por: Huang, Jun, et al.
Publicado: (2012)

Screening of a Small Molecule Compound Library Identifies Toosendanin as an Inhibitor Against Bunyavirus and SARS-CoV-2
por: Li, Shufen, et al.
Publicado: (2021)

In vitro metabolic characterization of the SARS-CoV-2 papain-like protease inhibitors GRL0617 and HY-17542
por: Cho, Hyunki, et al.
Publicado: (2023)

Bioabsorbable Bypass Grafts Biofunctionalised with RGD Have Enhanced Biophysical Properties and Endothelialisation Tested In vivo
por: Antonova, Larisa V., et al.
Publicado: (2016)

Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen
por: Rodon, Jordi, et al.
Publicado: (2021)

Identification of highly effective inhibitors against SARS-CoV-2 main protease: From virtual screening to in vitro study
por: Wang, Hu, et al.
Publicado: (2022)

Can the SARS-CoV-2 Spike Protein Bind Integrins Independent of the RGD Sequence?
por: Beaudoin, Christopher A., et al.
Publicado: (2021)

An update on SARS-CoV-2 immunization and future directions
por: Rana, Rashmi, et al.
Publicado: (2023)

Deletion of the RGD motif in LON-2/glypican is associated with morphological abnormalities
por: Park, Aileen, et al.
Publicado: (2021)

Ugonin J Acts as a SARS-CoV-2 3C-like Protease Inhibitor and Exhibits Anti-inflammatory Properties
por: Chiou, Wei-Chung, et al.
Publicado: (2021)

Therapeutic strategies for anchored kinases and phosphatases: exploiting short linear motifs and intrinsic disorder
por: Nygren, Patrick J., et al.
Publicado: (2015)

Inflammation Pharmacological Reaction and YMDD Mutational Patterns in Lamivudine Therapeutics Hepatitis B Virus
por: Liu, Hongcan, et al.
Publicado: (2021)

Structural and Functional RNA Motifs of SARS-CoV-2 and Influenza A Virus as a Target of Viral Inhibitors
por: Szczesniak, Izabela, et al.
Publicado: (2023)

Discovery of New Potent anti-MERS CoV Fusion Inhibitors
por: Kandeel, Mahmoud, et al.
Publicado: (2021)

Discovery of genistein derivatives as potential SARS-CoV-2 main protease inhibitors by virtual screening, molecular dynamics simulations and ADMET analysis
por: Liu, Jiawei, et al.
Publicado: (2022)

Computer-aided drug design for virtual-screening and active-predicting of main protease (M(pro)) inhibitors against SARS-CoV-2
por: Dai, Renhui, et al.
Publicado: (2023)

An Evaluation of Traditional Persian Medicine for the Management of SARS-CoV-2
por: Bahramsoltani, Roodabeh, et al.
Publicado: (2020)

Editorial: The Mechanisms of Action of Anti-SARS-CoV-2 Drugs
por: Zhong, Wu, et al.
Publicado: (2022)

Lactoferrin Against SARS-CoV-2: In Vitro and In Silico Evidences
por: Campione, Elena, et al.
Publicado: (2021)

SARS-CoV-2: Pathogenesis, Molecular Targets and Experimental Models
por: Kanimozhi, G., et al.
Publicado: (2021)

Virus hunters: Discovering the evolutionary origins of SARS-CoV-2
por: Banerjee, Arinjay
Publicado: (2021)

Construction of the Enterococcal Strain Expressing Immunogenic Fragment of SARS-Cov-2 Virus
por: Suvorov, Alexander, et al.
Publicado: (2022)

1,2,3,4,6-Pentagalloyl Glucose, a RBD-ACE2 Binding Inhibitor to Prevent SARS-CoV-2 Infection
por: Chen, Rui Hong, et al.
Publicado: (2021)

RGD v2.0: a major update of the ruminant functional and evolutionary genomics database
por: Fu, Weiwei, et al.
Publicado: (2021)

LIC12254 Is a Leptospiral Protein That Interacts with Integrins via the RGD Motif
por: Cavenague, Maria F., et al.
Publicado: (2023)

Modeling of SARS-CoV-2 Treatment Effects for Informed Drug Repurposing
por: Kern, Charlotte, et al.
Publicado: (2021)

Natural Bioactive Molecules as Potential Agents Against SARS-CoV-2
por: Chen, Wei, et al.
Publicado: (2021)

Anti–SARS-CoV-2 Natural Products as Potentially Therapeutic Agents
por: Kim, Cheorl-Ho
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rujqruup995hf1rb31c9mtn73e